136 related articles for article (PubMed ID: 34453501)
1. O-prenylated carbostyrils as a novel class of 15-lipoxygenase inhibitors: Synthesis, characterization, and inhibitory assessment.
Alavi SJ; Zebarjadi A; Bafghi MH; Orafai H; Sadeghian H
Chem Biol Drug Des; 2021 Nov; 98(5):894-902. PubMed ID: 34453501
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors.
Iranshahi M; Jabbari A; Orafaie A; Mehri R; Zeraatkar S; Ahmadi T; Alimardani M; Sadeghian H
Eur J Med Chem; 2012 Nov; 57():134-42. PubMed ID: 23047230
[TBL] [Abstract][Full Text] [Related]
3. O-prenylated 3-carboxycoumarins as a novel class of 15-LOX-1 inhibitors.
Jabbari A; Mousavian M; Seyedi SM; Bakavoli M; Sadeghian H
PLoS One; 2017; 12(2):e0171789. PubMed ID: 28182779
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR studies of 3-allyl-4-prenyloxyaniline amides as potent 15-lipoxygenase inhibitors.
Jabbari A; Davoodnejad M; Alimardani M; Assadieskandar A; Sadeghian A; Safdari H; Movaffagh J; Sadeghian H
Bioorg Med Chem; 2012 Sep; 20(18):5518-26. PubMed ID: 22917856
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and structure-activity relationship study of O-prenylated 3-acetylcoumarins as potent inhibitors of soybean 15-lipoxygenase.
Zerangnasrabad S; Jabbari A; Khavari Moghadam E; Sadeghian H; Seyedi SM
Drug Dev Res; 2021 Sep; 82(6):826-834. PubMed ID: 33416204
[TBL] [Abstract][Full Text] [Related]
6. Structural modifications of coumarin derivatives: Determination of antioxidant and lipoxygenase (LOX) inhibitory activity.
Roussaki M; Zelianaios K; Kavetsou E; Hamilakis S; Hadjipavlou-Litina D; Kontogiorgis C; Liargkova T; Detsi A
Bioorg Med Chem; 2014 Dec; 22(23):6586-6594. PubMed ID: 25456384
[TBL] [Abstract][Full Text] [Related]
7. Novel quinolinone-pyrazoline hybrids: synthesis and evaluation of antioxidant and lipoxygenase inhibitory activity.
Kostopoulou I; Diassakou A; Kavetsou E; Kritsi E; Zoumpoulakis P; Pontiki E; Hadjipavlou-Litina D; Detsi A
Mol Divers; 2021 May; 25(2):723-740. PubMed ID: 32065346
[TBL] [Abstract][Full Text] [Related]
8. Investigating the Anti-tumor and Apoptosis-inducing Effects of Coumarin Derivatives as Potent 15-Lipoxygenase Inhibitors on PC-3 Prostate Cancer Cells.
Maleki F; Sadeghian H; Bahrami AR; Goftari SN; Matin MM
Anticancer Agents Med Chem; 2023; 23(15):1722-1730. PubMed ID: 37171011
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological screening of some novel amidocarbamate derivatives of ketoprofen.
Sahoo PK; Behera P
Eur J Med Chem; 2010 Jul; 45(7):3162-8. PubMed ID: 20434240
[TBL] [Abstract][Full Text] [Related]
10. Quinoline-based imidazole-fused heterocycles as new inhibitors of 15-lipoxygenase.
Dianat S; Moghimi S; Mahdavi M; Nadri H; Moradi A; Firoozpour L; Emami S; Mouradzadegun A; Shafiee A; Foroumadi A
J Enzyme Inhib Med Chem; 2016; 31(sup3):205-209. PubMed ID: 27424740
[TBL] [Abstract][Full Text] [Related]
11. Probing phenylcarbamoylazinane-1,2,4-triazole amides derivatives as lipoxygenase inhibitors along with cytotoxic, ADME and molecular docking studies.
Muzaffar S; Shahid W; Riaz N; Saleem M; Ashraf M; Aziz-Ur-Rehman ; Bashir B; Kaleem A; Al-Rashida M; Baral B; Bhattarai K; Gross H
Bioorg Chem; 2021 Feb; 107():104525. PubMed ID: 33317840
[TBL] [Abstract][Full Text] [Related]
12. A novel class of human 15-LOX-1 inhibitors based on 3-hydroxycoumarin.
Alavi SJ; Sadeghian H; Seyedi SM; Salimi A; Eshghi H
Chem Biol Drug Des; 2018 Jun; 91(6):1125-1132. PubMed ID: 29388345
[TBL] [Abstract][Full Text] [Related]
13. Identification of NSAIDs as lipoxygenase inhibitors through highly sensitive chemiluminescence method, expression analysis in mononuclear cells and computational studies.
Shahid W; Ejaz SA; Al-Rashida M; Saleem M; Ahmed M; Rahman J; Riaz N; Ashraf M
Bioorg Chem; 2021 May; 110():104818. PubMed ID: 33784531
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and docking study of 3-aroyl-1-(4-sulfamoylphenyl)thiourea derivatives as 15-lipoxygenase inhibitors.
Mahdavi M; Shirazi MS; Taherkhani R; Saeedi M; Alipour E; Moghadam FH; Moradi A; Nadri H; Emami S; Firoozpour L; Shafiee A; Foroumadi A
Eur J Med Chem; 2014 Jul; 82():308-13. PubMed ID: 24927051
[TBL] [Abstract][Full Text] [Related]
15. Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1.
Eleftheriadis N; Thee S; te Biesebeek J; van der Wouden P; Baas BJ; Dekker FJ
Eur J Med Chem; 2015 Apr; 94():265-75. PubMed ID: 25771032
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of soybean 15-lipoxygenase by naturally occurring acetophenones and derricidin.
Taddeo VA; Epifano F; Genovese S; Fiorito S
Nat Prod Commun; 2015 Apr; 10(4):589-90. PubMed ID: 25973483
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
[TBL] [Abstract][Full Text] [Related]
18. Allylphenols as a new class of human 15-lipoxygenase-1 inhibitors.
Alavi SJ; Seyedi SM; Saberi S; Safdari H; Eshghi H; Sadeghian H
Drug Dev Res; 2021 Apr; 82(2):259-266. PubMed ID: 33022099
[TBL] [Abstract][Full Text] [Related]
19. Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
Wisastra R; Ghizzoni M; Boltjes A; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2012 Aug; 20(16):5027-32. PubMed ID: 22789707
[TBL] [Abstract][Full Text] [Related]
20. Easy and rapid preparation of benzoylhydrazides and their diazene derivatives as inhibitors of 15-lipoxygenase.
Tirapegui C; Acevedo-Fuentes W; Dahech P; Torrent C; Barrias P; Rojas-Poblete M; Mascayano C
Bioorg Med Chem Lett; 2017 Apr; 27(8):1649-1653. PubMed ID: 28318946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
